文献速递哮喘

哮喘:从表型到内表型——超越2型炎症

Asthma: From Phenotypes to Endotypes-Beyond Type 2 Inflammation.
PubMed 文献 · Respirology · 2026-10-07

本综述提出哮喘评估应超越T2炎症状态,采用涵盖临床、结构与生理、炎症内表型三个域的内表型-表型框架。气道重塑是定义哮喘的核心结构内表型,但最难测量且需纵向评估。T2高哮喘已有多种生物制剂,T2低哮喘异质且难表征,未来多组学或可增强特征化。

要点

  • 哮喘评估应超越T2炎症,采用临床、结构生理、炎症三域内表型框架。
  • 气道重塑是核心结构内表型,与固定气流受限、气道高反应性等相关。
  • T2低哮喘异质难表征,适当选择患者时部分治疗研究显示获益。

核心结论

  • 采用内表型框架有助于以精准医学方法管理哮喘并促进新药研发。

研究设计与样本

  • 本文为综述,未报告系统检索范围与样本量。

主要发现

  • 内表型评估可在临床、结构与生理、炎症内表型三个域进行。
  • 临床域包括黏液高分泌、气道狭窄感知和肥胖相关哮喘。
  • 气道重塑与固定气流受限、气道高反应性、小气道功能障碍、肺功能下降和哮喘严重度相关。
  • T2高哮喘已有多种有效抗炎治疗包括生物制剂;T2低哮喘异质且难表征。
  • 新兴多组学方法可能在未来增强患者详细特征化。

临床怎么用

  • 临床可采用内表型-表型框架对哮喘患者进行精准评估与管理。
  • 需关注气道重塑的纵向测量需求,超越支气管活检。
  • 对T2低哮喘应适当特征化并选择患者后再考虑治疗研究中的获益策略。

局限性

  • 气道重塑是最难测量的参数,需纵向评估超越支气管活检。
  • T2低哮喘异质且潜在难以表征。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Asthma is a heterogeneous syndrome featuring variable pathophysiology, clinical presentation and treatment response. This review examines a comprehensive endotype-phenotype framework for asthma assessment with an emphasis on characteristics beyond T2 inflammatory status alone. Endo-phenotype assessment can be performed across three domains: clinical (symptoms, exacerbations, co-morbidities), structural and physiological, and inflammatory endotype. The clinical domain includes mucus hypersecretion, perception of airway narrowing, and obesity-related asthma. Airway remodelling is the central, structural endo-phenotype that defines asthma, given its relationship with fixed airflow limitation, airway hyperresponsiveness, small airway dysfunction, lung function decline, and asthma severity. However, it is the most difficult parameter to measure, and it is increasingly recognised that there is a critical need to be able to measure it longitudinally, beyond bronchial biopsy. Finally, T2-high asthma is relatively well characterised with several effective anti-inflammatory therapies available, including a range of biologics. In contrast, T2-low asthma remains a heterogenous and potentially difficult to characterise endo-phenotype, although some treatment studies have demonstrated benefit when subjects have been appropriately characterised and selected. Emerging multi-omic approaches may enhance the detailed characterisation of patients in future. Adopting an endo-phenotype framework allows clinicians and researchers to confront the complexity of asthma, better manage patients with a precision medicine approach and enhance mechanistic understanding, which is critical for new therapeutics to be developed for asthma.

来源:Respirology,查看原文。版权归原作者所有。

引用

  1. Fernando M, King GG. Asthma: From Phenotypes to Endotypes-Beyond Type 2 Inflammation. Respirology. 2026. PMID: 42839791. doi:10.1002/resp.70322

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。